当前位置：药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 上市日期： -格式:2020-5-3
注册申请号： 市场分类： 活性成分： 持证企业：
 美国NDC未完成药物数据库文件21130条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
Insulin human
DRUG FOR FURTHER PROCESSING
0002-2045
Eli Lilly and Company
20131107
INSULIN HUMAN
DRUG FOR FURTHER PROCESSING
100
0002-2045_cff6dcc4-614f-4634-9823-8b2879df7748
Pemetrexed disodium
DRUG FOR FURTHER PROCESSING
0002-2059
Eli Lilly and Company
20080115
PEMETREXED DISODIUM HEPTAHYDRATE
DRUG FOR FURTHER PROCESSING
100
0002-2059_7cc2c69c-6ba3-4a22-94ae-c1790fc7c480
Pemetrexed disodium
DRUG FOR FURTHER PROCESSING
0002-2060
Eli Lilly and Company
20040213
PEMETREXED DISODIUM HEPTAHYDRATE
DRUG FOR FURTHER PROCESSING
500
0002-2060_7cc2c69c-6ba3-4a22-94ae-c1790fc7c480
ramucirumab
DRUG FOR FURTHER PROCESSING
0002-2129
Eli Lilly and Company
20140421
RAMUCIRUMAB
DRUG FOR FURTHER PROCESSING
10
0002-2129_3ddb35dc-be95-49e0-bef1-d67ad0dc474f
galcanezumab-gnlm
DRUG FOR FURTHER PROCESSING
0002-2377
Eli Lilly and Company
20180927
GALCANEZUMAB
DRUG FOR FURTHER PROCESSING
120
0002-2377_368df5d9-5eeb-49c7-a0dd-8a326ee5d78f
Insulin lispro-aabc
DRUG FOR FURTHER PROCESSING
0002-2415
Eli Lilly and Company
20200615
INSULIN LISPRO
DRUG FOR FURTHER PROCESSING
100
0002-2415_83fc33d1-b5d7-494c-bcc7-f1d5f511220d
ramucirumab
DRUG FOR FURTHER PROCESSING
0002-2477
Eli Lilly and Company
20140421
RAMUCIRUMAB
DRUG FOR FURTHER PROCESSING
10
0002-2477_3ddb35dc-be95-49e0-bef1-d67ad0dc474f
Insulin lispro-aabc
DRUG FOR FURTHER PROCESSING
0002-2479
Eli Lilly and Company
20200615
INSULIN LISPRO
DRUG FOR FURTHER PROCESSING
100
0002-2479_83fc33d1-b5d7-494c-bcc7-f1d5f511220d
Insulin lispro
DRUG FOR FURTHER PROCESSING
0002-2499
Eli Lilly and Company
20170606
INSULIN LISPRO
DRUG FOR FURTHER PROCESSING
100
0002-2499_0f2caf15-19e5-4e09-ad0d-265df1caa6b0
Insulin lispro-aabc
DRUG FOR FURTHER PROCESSING
0002-2509
Eli Lilly and Company
20200615
INSULIN LISPRO
DRUG FOR FURTHER PROCESSING
100
0002-2509_83fc33d1-b5d7-494c-bcc7-f1d5f511220d
Insulin human
DRUG FOR FURTHER PROCESSING
0002-2510
Eli Lilly and Company
19890626
INSULIN HUMAN
DRUG FOR FURTHER PROCESSING
100
0002-2510_cff6dcc4-614f-4634-9823-8b2879df7748
Insulin lispro-aabc
DRUG FOR FURTHER PROCESSING
0002-2572
Eli Lilly and Company
20200615
INSULIN LISPRO
DRUG FOR FURTHER PROCESSING
100
0002-2572_83fc33d1-b5d7-494c-bcc7-f1d5f511220d
Insulin lispro
DRUG FOR FURTHER PROCESSING
0002-2576
Eli Lilly and Company
19960614
INSULIN LISPRO
DRUG FOR FURTHER PROCESSING
100
0002-2576_0f2caf15-19e5-4e09-ad0d-265df1caa6b0
Insulin lispro-aabc
DRUG FOR FURTHER PROCESSING
0002-2578
Eli Lilly and Company
20200615
INSULIN LISPRO
DRUG FOR FURTHER PROCESSING
200
0002-2578_83fc33d1-b5d7-494c-bcc7-f1d5f511220d
galcanezumab-gnlm
DRUG FOR FURTHER PROCESSING
0002-3115
Eli Lilly and Company
20190604
GALCANEZUMAB
DRUG FOR FURTHER PROCESSING
100
0002-3115_368df5d9-5eeb-49c7-a0dd-8a326ee5d78f
Insulin lispro
DRUG FOR FURTHER PROCESSING
0002-6007
Eli Lilly and Company
20070906
INSULIN LISPRO
DRUG FOR FURTHER PROCESSING
100
0002-6007_0f2caf15-19e5-4e09-ad0d-265df1caa6b0
Insulin human
BULK INGREDIENT
0002-9307
Eli Lilly and Company
19821028
INSULIN HUMAN
BULK INGREDIENT
1
0002-9307_fc7b16e4-5f8a-4344-8da6-bdbca19b4751
Insulin glargine
BULK INGREDIENT
0002-9524
Eli Lilly and Company
20141216
INSULIN GLARGINE
BULK INGREDIENT
1
0002-9524_6a51962a-de52-443b-bf25-5fa0b676909e
suvorexant
DRUG FOR FURTHER PROCESSING
0006-0001
Merck Sharp & Dohme LLC.
20140815
SUVOREXANT
DRUG FOR FURTHER PROCESSING
5
0006-0001_04380331-421e-49f5-8dcc-d896fc8094e5
suvorexant
DRUG FOR FURTHER PROCESSING
0006-0002
Merck Sharp & Dohme LLC.
20140815
SUVOREXANT
DRUG FOR FURTHER PROCESSING
10
0006-0002_04380331-421e-49f5-8dcc-d896fc8094e5
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3